SILEXION THERAPEUTICS CORP (SLXN) Stock Income Statement
NASDAQ:SLXN - Nasdaq - KYG1281K1224 - Common Stock - Currency: USD
| TTM (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 981.70K | 1.10M | 1.11M | 770.00K | 200.00K | |||
| Selling, General, and Administrative Expenses | 973.60K | 1.12M | 1.23M | 940.00K | N/A | |||
| Operating Income | -981.70K | -1.10M | -1.11M | -770.00K | -200.00K | |||
| Interest Income/Expense | 453.60K | 1.36M | 1.69M | 10.00K | N/A | |||
| Income Before Taxes | -528.00K | 263.10K | 580.00K | -760.00K | -200.00K | |||
| Net Income | -528.00K | 263.10K | 580.00K | -760.00K | -200.00K | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.39 | 0.39 | 0.04 | -0.06 | -0.01 | |||
| Statistics | ||||||||
All data in USD